Default company panoramic image

HOCOR Cardiovascular Technologies

We develop the next generation transcatheter aortic valve replacement system.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Honolulu, HI, USA
  • Currency USD
  • Founded August 2007
  • Website

Company Summary

HOCOR is developing a hemodynamic support catheter (HOCOR-TAV) for acute severe aortic regurgitation with the specific aim to allow for aortic valve pretreatment (debulking, resection) prior to prosthetic-valve implantation. The HOCOR-TAV is a frontier technology providing less complications, excellent short-term and superior long-term prosthetic-valve durability. HOCOR hopes to replace conventional surgery to include all risks patients.


  • Default avatar
    Paul C. Ho
    President, CEO

    Founder of HOCOR and inventor of the HOCOR system, Dr. Ho practices Clinical and Interventional Cardiology in Honolulu, Hawaii and has performed over 5,000 percutaneous cardiac procedures. He has been involved in numerous clinical studies of cardiovascular devices. Trained as a Biomedical Engineer at the University of Pennsylvania, he received his Medicine and Cardiology training at the Dartmouth and Harvard Medical Schools.


  • Default avatar
    Stewart Pressman, JD McCorriston Miller Mukai MacKinnon LLP
    Default avatar
    Alan Schlissel, JD, MBA KMH-LLP